630
Participants
Start Date
January 31, 2025
Primary Completion Date
January 31, 2027
Study Completion Date
October 31, 2027
Standardized assessments, guided tumor biopsy and biobanking
"Standardized assessment of Scores~* Guided tumor biopsy in patients listed for hepatocellular carcinoma with active tumor at listing in centers not perfoming tumor biopsy on a routine basis~* Additional blood sampling for biobanking and subsequent analysis of innovative biomarkers and OMICs~* Urine sampling for biobanking and subsequent analysis of innovative biomarkers~* Ascite sampling for biobanking and subsequent analysis~* Tumor sampling for biobanking and subsequent analysis~* Centralized assay for routine biomarkers"
Standardized assessments and biobanking
"* Standardized assessment of Scores~* Additional blood sampling for biobanking and subsequent analysis of innovative biomarkers and OMICs~* Urine sampling for biobanking and subsequent analysis of innovative biomarkers~* Ascite sampling for biobanking and subsequent analysis~* Tumor sampling for biobanking and subsequent analysis~* Centralized assay for routine biomarkers"
Hospital Henri Mondor, Department of Hepatology, Créteil
Department of Gastroenterology and Hepatology Universitair Ziekenhuis Gent, Ghent
Italian National Transplant Center, Roma
Center for Liver Tumors Leiden of the Leiden University Medical Center (LUMC), Leiden
"Universitätsklinikum Schleswig - Holstein , UKSH · Transplantation Medicine"
Collaborators (1)
University of Luxembourg
OTHER
Hospital Universitario La Fe
OTHER
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK (ECRIN)
UNKNOWN
Ophiomics - Precision Medicine
UNKNOWN
EF CLIF
UNKNOWN
INSERM 1149
UNKNOWN
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
Assistance Publique - Hôpitaux de Paris
OTHER